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Tyrosine kinase Pyk2 mediates G-protein-coupled receptor
regulation of the Ewing sarcoma RNA-binding protein EWS
Jason S. Felsch*, William S. Lane† and Ernest G. Peralta*
Ewing family tumors result from the effects of
chromosomal translocations that fuse the Ewing
sarcoma (EWS) gene to various genes encoding
transcription factors [1]. The resulting chimeric EWS
fusion proteins are transcriptional activators with
transforming potential that have received much study
[2]. By contrast, the cellular function of somatic EWS
remains obscure. EWS belongs to a family of
RNA-binding proteins thought to play role in RNA
synthesis or processing [3,4]. Here, we show that EWS
interacts with Pyk2, a protein tyrosine kinase implicated
in a variety of signal transduction processes [5–8].
G-protein-coupled receptor signaling and other stimuli
of Pyk2 kinase activity significantly block the
interaction between EWS and Pyk2. Furthermore, as
assessed by sucrose gradient centrifugation, EWS
partitions with dense ribosome-containing fractions in
a manner that is enhanced by signaling from the
G-protein-coupled m1 muscarinic acetylcholine receptor
(mAChR). We conclude that extranuclear EWS is a
previously unrecognized target of G-protein-coupled
receptor regulation.
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Results and discussion
The m1 mAChR is coupled to the Gαq/11 protein and regu-
lates a variety of enzymes including Pyk2 [8,9]. To investi-
gate how Pyk2 enzymology is regulated by the m1
mAChR, we purified a epitope-tagged form of Pyk2
(Pyk2–HSV, containing an 11 amino acid epitope tag
derived from herpes simplex virus, HSV) from the human
embryonic kidney cell line HEK-m1P, which exogenously
expresses this tagged variant of Pyk2 together with m1
mAChR and is derived from the parental HEK cell line [8].
Sequential steps in that purification revealed surprisingly
that a protein with an apparent molecular weight of 90 kDa
co-purified with Pyk2–HSV (Figure 1a). Sequencing by
mass spectroscopy of tryptic peptides derived from the
90 kDa band identified it to be EWS. We also observed
that Pyk2 and EWS co-immunoprecipitated from cell
extracts (Figure 1b). Rat liver GN4 [7] cells and rat
pheochromacytoma PC12 cells [5] both express Pyk2
endogenously. HEK-m1P, GN4 and PC12 cells all express
Triton-soluble endogenous EWS detectable by western
blotting. Immunoprecipitates obtained using antibodies
against either the HSV epitope tag or Pyk2 contained
EWS. Reciprocal immunoprecipitates obtained using an
antibody against EWS contained Pyk2 immunoreactivity.
These results indicate that a specific Pyk2–EWS associa-
tion may occur in all cells expressing both proteins.
To identify the regions of Pyk2 and EWS responsible for
their association, glutathione-S-transferase (GST)-fusion
proteins bearing different domains of Pyk2 or EWS were
produced. In ‘pull-down’ assays, a GST-fusion protein
bearing the amino-terminal third of EWS (EWS-N) specif-
ically precipitated Pyk2–HSV from HEK-m1P cell lysates
(Figure 1c). Conversely, EWS associated with a GST-
fusion protein bearing a stretch of amino acids (the C1
region) from the carboxyl terminus of Pyk2 (Figure 1c).
To explore whether these associations represent direct
physical associations, we repeated the pull-down assays
replacing the cell lysates with either purified Pyk2–HSV
or bacterially expressed, histidine-tagged EWS
(EWS–His6; Figure 1c). With other cellular proteins
essentially absent, Pyk2–HSV again bound specifically to
the EWS-N GST-fusion protein. Furthermore, the Pyk2-
C1 GST-fusion protein specifically bound the purified
recombinant EWS–His6. These results indicate that the
Pyk2-C1 region supports a direct interaction with the
amino terminus of EWS.
We also found that activation of Pyk2 by Gαq/11-coupled
signaling displaced EWS from its association with Pyk2
(Figure 2a). Gαq/11-coupled signaling and phorbol myris-
tate acetate (PMA) activate Pyk2 in HEK-m1P and GN4
cells [7,8]. HEK-m1P cells express Pyk2–HSV and the
m1 mAChR exogenously, whereas GN4 cells express
Pyk2 and the angiotensin II receptor endogenously. We
examined whether G-protein-coupled receptor signaling
affected the EWS–Pyk2 association. Pyk2 was immuno-
precipitated from lysates of HEK-m1P cells before and
after stimulation with the mAChR agonist carbachol or
after incubation with serum. Both carbachol and serum
caused EWS to dissociate from the Pyk2 immune
complex. Similarly, treating GN4 cells with either the
G-protein-coupled receptor agonist angiotensin II or
PMA also blocked the EWS–Pyk2 association. Parallel
experiments were performed using HEK cell lines
expressing m1 mAChR together with either a Pyk2
variant with diminished kinase activity (HEK-
m1P/K457A) or a Pyk2 variant with the autophosphoryla-
tion site Tyr402 mutated to phenylalanine
(HEK-m1P/Y402F; Figure 2b) [8]. Pyk2 stimulation in
these cells did not prevent EWS from binding to Pyk2,
indicating that the ability of Pyk2 stimuli to dissociate
EWS from Pyk2 depends on both Pyk2 catalytic activity
and autophosphorylation at Tyr402.
Because earlier reports predicted a role for EWS in tran-
scription, its interaction with a cytosolic tyrosine kinase
led us to assess the intracellular location of EWS by sub-
cellular fractionation [10] (Figure 3a). HEK-m1P cell
homogenates were subjected to differential centrifugation,
yielding four fractions that were characterized by
immunoblotting [11]. The nuclear fraction contained most
of the histone immunoreactivity and DNA. By compari-
son, ribosomal P antigen was found in the ribosomal frac-
tion. The ribosomal fraction may also contain plasma
membrane components because the epidermal growth
factor receptor (EGFR) was also present in this fraction.
Antibodies against either the amino terminus or the car-
boxyl terminus of EWS could not detect any EWS in the
nuclear fraction. Rather, ribosomal and cytosolic fractions
harbored the EWS immunoreactivity. As expected,
Pyk2–HSV was found only in the cytosolic fractions. The
discovery that EWS is also found as an extranuclear
protein contrasts earlier reports of cellular EWS in prepa-
rations described as nuclear [10,12].
To further clarify our understanding of where in the cell
EWS is likely to function, we subjected the EWS-contain-
ing fractions from our initial fractionation to sucrose gradi-
ent centrifugation (Figure 3b). Three different cell lines
expressing the m1 mAChR were used: HEK-m1P,
HEK-m1P/K457A, and the HEK-m1 parental line. Serum-
starved cells were either left unstimulated or treated with
carbachol and were compared with serum-fed cells. After
pelleting the nuclei and mitochondria, the supernatant
was layered onto a sucrose gradient to separate ribosomes
from the lighter cytosolic and membrane components.
Neither the presence of serum nor stimulation by carba-
chol affected the partitioning of ribosomes or Pyk2, which
are clearly separated into high-density and low-density
regions, respectively. Similarly, in the parental HEK-m1
cells, which lack Pyk2 expression, EWS sediments to ribo-
somal fractions regardless of cell treatment. In cells
expressing Pyk2, however, EWS partitioning was sensitive
to the presence of serum and to the presence of carbachol.
In unstimulated cells expressing either Pyk2 or kinase-
inactive Pyk2 the majority of EWS was detected in low-
density cytosolic fractions. When those cells were
incubated in the presence of serum and were actively
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EWS associates with Pyk2. (a) SYPRO-orange-stained
SDS–polyacrylamide gel showing fractions from sequential steps in an
immunopurification of HSV-tagged Pyk2. Lysate represents the
starting material and IP (lysis buffer), low salt and high salt represent
increasingly stringent salt washes preceding final elution with
competitive peptide. Molecular weight markers (MW) are also shown.
(b) Co-immunoprecipitation of EWS and Pyk2 from different cell
types. HEK-m1P, GN4 and PC12 cell lysates were
immunoprecipitated with IgG control antibodies (control), or
antibodies against the carboxyl terminus of EWS (EWS-C), the HSV
epitope (HSV), the amino terminus of Pyk2 (Pyk2-N), or focal adhesion
kinase (Fak). The immunoprecipitates were then examined by western
blotting using antibodies against Pyk2, the amino terminus of EWS
(EWS-N) or Fak. (c) Identification of the interacting domains of EWS
and Pyk2. The schematic diagram denotes boundaries chosen for the
construction of GST-fusion proteins containing regions of EWS or
Pyk2. Lysates of HEK-m1P cells were incubated with the indicated
GST-fusion protein bound to glutathione–agarose beads, and the
beads washed. The resulting samples were then examined by western
blotting with monoclonal anti-Pyk2 or anti-EWS-C antibodies (upper
panels). Purified Pyk2–HSV or EWS–His6 were analyzed in a similar
manner as the cell lysates and the resulting western blots are shown
in the lower panels.
growing, EWS localized to the high-density ribosome-con-
taining fractions. Stimulating the m1 mAChR with carba-
chol in the absence of serum caused half of the EWS to
partition with the ribosomal fraction. Catalytic activation
of Pyk2 may play a role in the mAChR-dependent shift of
EWS partitioning because, in cells expressing kinase-defi-
cient Pyk2, EWS was reluctant to shift to ribosomal frac-
tions in response to carbachol. These findings show that
Pyk2 mediates G-protein-coupled receptor regulation of
EWS in its association with other cellular components —
possibly ribosomes.
EWS interacts with a region of Bruton’s tyrosine kinase
(Btk) and has been identified as a phosphotyrosine-con-
taining protein in B cells [13]. Like Pyk2, Btk is a
B-cell-expressed cytosolic tyrosine kinase activated by
Gαq/11-coupled signaling [14]. We examined whether m1
mAChR stimulation could specifically cause EWS phos-
phorylation in 32P-labeled HEK-m1P cells but we could
not detect any EWS phosphorylation. Neither did we
observe any specific in vitro phosphorylation of EWS by
purified Pyk2–HSV (data not shown). As proposed by
Guinamard et al. [13], EWS phosphorylation may
depend on specific cell-cycle conditions or on cell type.
Certain proteins, such as Src family kinases and the
adaptor protein Grb2, are induced to interact with Pyk2
by the molecular events accompanying Pyk2 activation
[5,8,15]. We view EWS as a Pyk2-interacting protein
that, upon Pyk2 activation, is induced to dissociate from
Pyk2. We propose that muscarinic signaling and the
events accompanying Pyk2 activation cause a change in
the molecular configuration of Pyk2 such that EWS is
much less able to bind to the kinase, partitioning instead
to ribosome-associated structures. In summary, our find-
ings indicate that a potential role for EWS in gene
expression includes an extranuclear function. Moreover,
this function is susceptible to regulation by
Gαq/11-coupled receptor signaling and depends on both
Pyk2 kinase activity and Pyk2 autophosphorylation.
Materials and methods
Cell lines and DNA constructs
Cell lines were derived and cultured as described [5,7,8]. Pyk2 and
EWS DNA fragments were amplified by PCR and inserted into pGEX
(Pharmacia) generating plasmids encoding the following GST-fusion
proteins: EWS amino acids 1–252 (EWS-N) or 252–656 (EWS-C);
Pyk2 amino acids 2–130 (N1), 130–323 (N2), 323–656 (KD),
656–797 (C1) or 797–1009 (C2).
Immunoprecipitations, protein purification and interaction assays
HSV-tagged Pyk2 from serum-starved HEK-m1P cells was immuno-
precipitated as described [8]. For immunopurification, the beads were
washed with lysis buffer (IP), lysis buffer plus 450 mM KCl (low salt),
or lysis buffer plus 700 mM KCl (high salt). Pyk2–HSV was eluted
with HSV peptide. Bacterially expressed EWS–His6 was partially
purified over ProBond Resin (Invitrogen) following the manufacturer's
instructions. Experiments with GST-fusion proteins were performed
as described [16].
Subcellular fractionation and sucrose gradients 
Subcellular fractionation of serum-starved HEK-m1P cells was per-
formed as described with the omission of the 20 min 4,000 × g spin
[11], and keeping MgCl2 at 5 mM. The nuclear pellet was further puri-
fied and DNA content was assessed as described [17], with the resus-
pended pellet being layered over buffer with 2.2 M sucrose. The nuclei
were then solubilized by treatment with nuclease, NaCl and Triton as
described [12]. For some experiments, after the nuclei, mitochondria
and microsomes were pelleted, the remaining supernatant was frac-
tionated by sucrose density gradient centrifugation. The post-microso-
mal supernatant (0.5 ml) was layered onto a preformed 4 ml 5–30%
w/v sucrose gradient according to Glover et al. [11].
Supplementary material
Additional methodological details and a figure showing the purity of the
GST-fusion proteins are published with this paper on the internet.
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Figure 2
EWS dissociates from Pyk2 upon Pyk2 activation. (a) Serum-starved
HEK-m1P cells or GN4 cells were left untreated (IgG and control) or
were stimulated with 1 µM carbachol (carb) for 5 min, 10% fetal bovine
serum (FBS) for 3 h, 5 µM angiotensin II (AgII) for 10 min, or 0.5 µM
PMA for 5 min. The cells were then lysed and the lysates subjected to
immunoprecipitation with anti-HSV antibodies (for the HEK-m1P cells) or
Pyk2-N antibodies (for the GN4 cells). The resulting immune complexes
were washed and immunoblotted with anti-EWS-C (upper panel) or
monoclonal anti-Pyk2 (lower panel) antibodies. (b) Cell lysates were
analyzed as in (a), except that the cells used in this experiment expressed
Pyk2 variants that lacked either full kinase activity (HEK-m1P/K457A) or
carried a mutation of the key autophosphorylation site, Tyr402
(HEK-m1P/Y402F). In this experiment, immunoblotting for Pyk2 was
performed using anti-HSV antibodies.
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Figure 3
Subcellular fractionation reveals a regulated
association between EWS and Pyk2.
(a) Differential centrifugation of serum-starved
HEK-m1P cell preparations yielded the
following four fractions: a 480 × g nuclear
fraction (nuc), a 20,000 × g mitochondrial
fraction (mito), a ribosome- and membrane-rich
100,000 × g fraction (ribo), and a cytosolic
supernatant fraction (cyto). Fractions were
analyzed by western blotting with anti-Pyk2,
anti-EWS-C (EWS), anti-EGFR, anti-ribosomal
P antigen (ribo P), anti-mitochondrial antigen
(mito), or anti-histone antibodies as indicated.
A graph of DNA content in each of the
fractions, expressed as a percentage of the
total, is shown below the blots. (b) Pyk2,
muscarinic signaling, and serum regulate the
association of EWS with ribosomes. HEK-
m1P, HEK-m1P/K457A and HEK-m1 cells
were serum-starved and treated with or
without carbachol (1 µM for 1 min), or were
incubated with serum. The cells were then
fractionated by differential centrifugation to
remove nuclei and mitochondria as above. The
remaining mixture was subjected to sucrose
gradient (5–30% w/v) centrifugation. In each
column, sucrose gradient fractions of each cell
line are analyzed. The sucrose concentration
(w/v) was determined by refractometry (x
axes). The absorbance at 254 nm for each
fraction is expressed as a percentage of total
absorbance. Fractions were also
immunoblotted with anti-HSV (Pyk2), anti-
EWS-C (EWS), or anti-ribosomal P antigen
(ribo P). The resulting bands on the western
blots were quantitated by densitometry and
values expressed as percentage of total
immunoreactivity for the gradient. The western
blots in the insets of each graph show the
analyses of the HEK-m1P cell line.
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Supplementary materials and methods
Materials 
Antibodies used were: anti-HSV (Novagen); anti-Pyk2 and Fak (Trans-
duction Labs); generic mouse, rabbit, and goat IgG (Jackson
ImmunoResearch Laboratories); anti-EWS-C, anti-EWS-N, anti-
Pyk2-N, and horseradish peroxidase (HRP)-conjugated anti-goat IgG
(Santa Cruz Biotechnology); anti-ribosomal P antigen, anti-mitochon-
drial antigen, and anti-histone (ImmunoVision); and anti-EGFR
(Upstate Biotechnology). 
DNA constructs 
The gene encoding EWS [S1] was amplified by PCR from HEK-m1P
cDNA to generate a 2.0 kb DNA fragment flanked by a 5′ EcoRI site
and 3′ XhoI and HindIII sites. This fragment was subcloned by
EcoRI–HindIII digest into pRSET-B (Invitrogen) to generate pRSET-
B-EWS that encodes an EWS variant with a carboxy-terminal hexahisti-
dine tag, EWS–His6. Using pRSET-B-EWS and pCMV-Pyk2–HSV
[S2], DNA fragments were amplified by PCR to generate pGEX (Phar-
macia) plasmids encoding the following GST-fusion proteins: EWS
amino acids 1–252 (EWS-N) or 252–656 (EWS-C); Pyk2 amino acids
2–130 (N1), 130–323 (N2), 323–656 (KD), 656–797 (C1) or
797–1009 (C2).
Protein purification 
Bacterially expressed His-tagged EWS was partially purified by 50 mM
imidazole elution from ProBond Resin (Invitrogen) following the manu-
facturer’s method. The eluate was dialyzed against 20 mM Tris pH 7.8,
25 mM KCl, and further purified by FPLC with a Mono S column (Phar-
macia) developed with a gradient of 25–1000 mM KCl. 
Subcellular fractionation 
According to the Glover method [S3], the nuclear fraction was derived
from the low-speed (480 × g) pellet further purified by the method of
Blobel [S4], the mitochondrial fraction represents an intermediate-speed
(20,000 × g) pellet, and the cytosolic fraction is the supernatant remain-
ing after ribosomes are pelleted with a high speed spin (100,000 × g).
For the ribosomal P antigen western blots, the 38 kDa band was used
for densitometric analysis. Prior to analysis by refractometry, UV
absorbance, or immunoblotting, fractions were normalized for total
protein content by colorimetric assay (BioRad Laboratories).
Sequencing by mass spectrometry (MS)
For sequence analysis, the 90 kDa band was visualized with GelCode
Blue and subjected to in-gel reduction, carboxyamidomethylation, and
tryptic digestion (Promega), and analyzed as follows. Multiple peptide
sequences were determined in a single run by microcapillary
(50 µm × 5 cm column, packed-in house with C18 support, 190 nl/min)
reverse-phase chromatography directly coupled to the nanoelectro-
spray tip (10 µm, New Objective) of a quadrupole ion trap mass spec-
trometer (Finnigan LCQ). The instrument was programmed to acquire
successive sets of three scan modes consisting of: full-scan MS over
alternating ranges of 395–760 m/z or 760–1200 m/z, followed by two
data-dependent scans on the most abundant ion in those full scans.
These data-dependent scans allowed the automatic acquisition of a
high-resolution scan to determine charge state and exact mass, and
MS/MS spectra for peptide sequence information. MS/MS spectra
were acquired with at a relative collision energy of 35% and an isola-
tion width of 2.5 µ. Interpretation of the resulting MS/MS spectra of the
peptides was facilitated by searching the NCBI protein database with
the algorithm Sequest [S5], followed by manual confirmation to identify
the protein as EWS.
Western blots and in vitro interaction assays 
Western blots and immunoprecipitations were performed essentially as
described [S2] with 20 µl of either protein A–Sepharose CL-4B (Phar-
macia), protein G–Sepharose CL-4B (ZYMED), or protein G–Agarose
Plus (Santa Cruz Biotechnology). Alterations to the protocol are as
follows: GN4 cells were passed 10 times through a pestle B dounce
homogenizer; two 60 min rounds of pre-clearing were performed with
washed beads pre-bound with a mixture of rabbit, mouse, and goat IgG
(2 µg each per 20 µl bead volume); immune complexes were washed
with lysis buffer containing 500 mM KCl, 0.05% Lubrol, and 1% v/v
glycerol, and then ‘desalted’ by two exchanges into the lysis buffer.
GST-fusion protein interaction assays were performed as described
[S6] with the exceptions that lysates were pre-cleared as above and
400 mM KCl was added. Prior to incubation of GST-fusion proteins
with either purified EWS–His6 or Pyk2–HSV, the pure protein was dia-
lyzed into interaction buffer and brought to a concentration of
10 mg/ml. For the quantitation presented in Figure 2, the local back-
ground-subtracted values for EWS and Pyk2 bands were measured by
densitometry. EWS values were normalized for the apparent amount of
Pyk2 present.
References
S1. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, et
al.: Gene fusion with an ETS DNA-binding domain caused by
chromosome translocation in human tumours. Nature 1992,
359:162-165.
S2. Felsch JS, Cachero TG, Peralta EG: Activation of protein tyrosine
kinase PYK2 by the m1 muscarinic acetylcholine receptor. Proc
Natl Acad Sci USA 1998, 95:5051-5056.
S3. Glover CJ, Hartman KD, Felsted RL: Human N-myristoyltransferase
amino-terminal domain involved in targeting the enzyme to the
ribosomal subcellular fraction. J Biol Chem 1997, 
272:28680-28689.
Supplementary material
Figure S1
SYPRO-orange-stained SDS–polyacrylamide gel showing the relative
purity of the GST-fusion proteins used in Figure 1. For clarity, negative
images of the SYPRO-orange-stained gels are presented.
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